Jim Cramer identifies his favorite portfolio stock — and it’s not a big tech name
Jim Cramer has multiple reasons to like Procter & Gamble , even as the consumer packaged goods sector remains out of favor. “Procter is my favorite stock,” Jim said Tuesday during the Morning Meeting for Investing Club members, pointing to what he described as an increasingly attractive setup for long-term Continue Reading
Obesity pills from Novo Nordisk, Eli Lilly are coming
Daniel Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. GLP-1 pills for obesity are closer than ever. 2026 is likely the year that Continue Reading
Nasdaq moves to near 24-hour trading. Some say that’s a bad idea
The Nasdaq MarketSite in New York, Nov. 20, 2025. Michael Nagle | Bloomberg | Getty Images Nasdaq is moving closer to around-the-clock stock trading, a shift that some on Wall Street are calling unnecessary — and potentially destabilizing. The exchange said it plans to submit paperwork to the Securities and Continue Reading
Bank of America survey shows record low cash level
While the market may be stalling into year-end, investors are keeping the faith, Bank of America data shows. The share of portfolios in cash fell to a record low 3.3% in December, according to the bank’s Global Fund Manager survey. That’s down from 3.7%. Michael Hartnett, chief investment strategist at Continue Reading
Big Tech faces key House vote on reforming permit process
Big Tech heavy hitters such as OpenAI, Meta, and Microsoft are pushing for Congress to advance legislation to reform the process for obtaining federal permits for projects to build out artificial intelligence infrastructure in the United States. Backers of the bill, the SPEED Act, argue it is key to helping Continue Reading
Hassett says Fed independence is ‘really important’ and chair candidates shouldn’t be disqualified for being Trump’s friend
National Economic Council Director Kevin Hassett, one of the finalists for the Federal Reserve chair job, showed support Tuesday for central bank independence. With President Donald Trump apparently in the final days of picking a successor to Jerome Powell at the Fed, Hassett declined in a CNBC interview to directly Continue Reading
Pfizer 2026 guidance shows Metsera, Seagen deals will take time to pay off
Smith Collection | Archive Photos | Getty Images Pfizer on Tuesday forecast modest 2026 guidance as it looks to longer-term investments in its pipeline to counter waning Covid product sales and declines from older drugs. Those hurdles aren’t surprising or new for Pfizer, which has seen a dramatic decline in Continue Reading
Stocks making the biggest moves premarket: PFE, ROKU, KHC
Check out the companies making headlines before the bell: Pfizer — The pharma giant issued disappointing 2026 earnings guidance. Pfizer a profit between $2.80 per share and $3 per share for the coming year. Analysts polled by LSEG expected earnings per share of $3.05 for 2026. The company also reaffirmed Continue Reading
Oil hits lowest since May, on pace for biggest decline in 7 years
Oil prices held on to most gains from the previous session in early trading on Thursday as investors awaited U.S.-China trade talks later in the day. Anton Petrus | Moment | Getty Images U.S. crude oil on Tuesday hit the lowest level since May, putting prices on pace for the Continue Reading
Kevin Warsh moves ahead in Fed chief race on Kalshi after Hassett pushback
Kevin Hassett, director of the National Economic Council (L), and Kevin Warsh, former governor of the U.S. Federal Reserve. Reuters Kevin Warsh has surged ahead of Kevin Hassett in prediction markets betting on who President Donald Trump will nominate as the next chair of the Federal Reserve, as doubts grow Continue Reading